AGP Picks
View all

Top health and wellness news from New Mexico

Provided by AGP

New Mexico Health Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on New Mexico Health Reporter.

Press releases published on May 7, 2026

Atsena Presents Positive Clinical Data from Its XLRS and LCA1 Gene Therapy Programs at ARVO 2026
Werewolf Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Updates
Aligos Therapeutics Reports Recent Business Progress and First Quarter 2026 Financial Results
LeonaBio Reports First Quarter 2026 Financial Results and Provides Business Update
Codexis Reports First Quarter 2026 Financial Results
Profound Medical Reports Strong First Quarter 2026 Financial Results
ICU Medical Announces First Quarter 2026 Results
Stryker completes acquisition of Amplitude Vascular Systems to add next-generation IVL technology to peripheral vascular portfolio
Vaxart Provides Business Update and Reports First Quarter 2026 Financial Results
Structure Therapeutics Reports First Quarter 2026 Financial Results and Recent Highlights
PacBio Announces First Quarter 2026 Financial Results
TOMI Environmental Solutions Highlights SteraMist Efficacy in Neutralizing Biohazards Amid Rising Hantavirus Concerns
Cytek Biosciences Reports First Quarter 2026 Financial Results
Omada Health Reports First Quarter 2026 Results
Outset Medical Reports First-Quarter Results
Catalyst Pharmaceuticals Cancels First Quarter 2026 Conference Call and Webcast
Bluejay Diagnostics Provides First Quarter 2026 Corporate Update
Celldex Reports First Quarter Financial Results and Provides Corporate Update
Tectonic Therapeutic Announces First Quarter 2026 Financial Results and Recent Business Highlights
Xenon Reports Q1 2026 Financial Results and Provides Business Update

Share us

on your social networks:

Sign up for:

New Mexico Health Reporter

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.